Relationship of ITPKA expression with the prognosis of breast cancer

by Jie Zhang, Sujie Zhang, Xiaoyan Li, Hongying Pi
Published 2021-04-01

Efficacy of Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural or Peritoneal Effusions

by Xin ZHANG, Yi HU, Jinliang WANG, Sujie ZHANG, Haitao TAO, Sun JING, Baishou WU
Published 2013-03-01

Demethylation of miR-9-3 and miR-193a Genes Suppresses Proliferation and Promotes Apoptosis in Non-Small Cell Lung Cancer Cell Lines

by Jinliang Wang, Bo Yang, Lu Han, Xiaoyan Li, Haitao Tao, Sujie Zhang, Yi Hu
Published 2013-12-01

Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer

by Qi Xiong, Boyu Qin, Lingli Xin, Bo Yang, Qi Song, Yu Wang, Sujie Zhang, Yi Hu
Published 2021-07-01

Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles

by Tingting Liu, Jiang Wang, Tao Li, Pengfei Cui, Baicun Hou, Chunxiao Zhuang, Ge Wei, Sujie Zhang, Hongxia Li, Yi Hu
Published 2021-08-01

Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer

by Pengfei Cui, Di Huang, Zhaozhen Wu, Haitao Tao, Sujie Zhang, Junxun Ma, Zhefeng Liu, Jinliang Wang, Ziwei Huang, Shixue Chen, Xuan Zheng, Yi Hu
Published 2020-05-01

The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors

by Zhaozhen Wu, Pengfei Cui, Haitao Tao, Sujie Zhang, Junxun Ma, Zhefeng Liu, Jinliang Wang, Yuanyu Qian, Shixue Chen, Ziwei Huang, Xuan Zheng, Di Huang, Yi Hu
Published 2021-02-01

Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy

by Lingling Li, Lingling Li, Chenghui Pi, Xin Yan, Jiangyue Lu, Xuhui Yang, Chunyu Wang, Xiaoyan Li, Sujie Zhang, Zhibo Zhang, Yi Sun, Yi Hu, Yi Hu
Published 2021-10-01

Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel for patients with non-small cell lung cancer who have progressed after platinum-based chemotherapy

by Fan Zhang, Di Huang, Lei Zhao, Tao Li, Sujie Zhang, Guoqing Zhang, Fang Yuan, Jie Zhang, Yuzi Zhang, Zhengyi Zhao, Longgang Cui, Jing Zhao, Guoqiang Wang, Shangli Cai, Yuezong Bai, Jinliang Wang, Yi Hu
Published 2020-07-01

Pretreatment hemoglobin level as a predictor to evaluate the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

by Zhibo Zhang, Fan Zhang, Fang Yuan, Ye Li, Junxun Ma, Qiuxiang Ou, Zhefeng Liu, Bo Yang, Lijie Wang, Haitao Tao, Sujie Zhang, Xiaoyan Li, Xiaoyu Zhi, Xiangwei Ge, Hua Bao, Xue Wu, Yi Hu, Jinliang Wang
Published 2020-11-01

Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis

by Shixue Chen, Shixue Chen, Zhibo Zhang, Xuan Zheng, Xuan Zheng, Haitao Tao, Sujie Zhang, Junxun Ma, Zhefeng Liu, Jinliang Wang, Yuanyu Qian, Pengfei Cui, Pengfei Cui, Di Huang, Di Huang, Ziwei Huang, Ziwei Huang, Zhaozhen Wu, Zhaozhen Wu, Yi Hu
Published 2021-04-01

Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

by Zhibo Zhang, Zhibo Zhang, Zhibo Zhang, Fang Yuan, Runzhe Chen, Ye Li, Junxun Ma, Xiang Yan, Lijie Wang, Fan Zhang, Haitao Tao, Dong Guo, Zhiyue Huang, Sujie Zhang, Xiaoyan Li, Xiaoyu Zhi, Xiaoyu Zhi, Xiangwei Ge, Xiangwei Ge, Yi Hu, Jinliang Wang
Published 2020-06-01